Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 144 Carcinoma, Non-Small-Cell Lung 51 Carcinoma, Transitional Cell 50 Melanoma 46 Urinary Bladder Neoplasms 42 Prostatic Neoplasms 32 Kidney Neoplasms 29 Neoplasm Metastasis 27 Colorectal Neoplasms 26 Squamous Cell Carcinoma of Head and Neck 21 Carcinoma, Hepatocellular 20 Triple Negative Breast Neoplasms 15 Neoplasms 15 Stomach Neoplasms 14 Ovarian Neoplasms 14 Clear-cell metastatic renal cell carcinoma 14 Lung Neoplasms 13 Uterine Cervical Neoplasms 12 Carcinoma, Merkel Cell 11 Small Cell Lung Carcinoma 9 Pancreatic Neoplasms 9 Head and Neck Neoplasms 8 Esophageal Neoplasms 7 Breast Neoplasms 7 Urethral Neoplasms 6 Endometrial Neoplasms 6 Cholangiocarcinoma 6 Urogenital Neoplasms 5 Skin Neoplasms 5 Recurrence 5

Interventions

balstilimab 1 Nivolumab 1 Ipilimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Renal Cell Carcinoma × Nivolumab × Genitourinary × Clear all

NCT05928806 2026-02-11

ARCITECT

Hoosier Cancer Research Network

Phase 2 Suspended

Advanced Renal Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡